US Patent Issued to CIRCULAR BIOTECH on Sept. 8 for "Autologous cancer tumour associated extrachromosomal circular DNA for use as a therapeutic vaccine" (Swedish Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,157, issued on Sept. 8, was assigned to CIRCULAR BIOTECH AB (Umea, Sweden).

"Autologous cancer tumour associated extrachromosomal circular DNA for use as a therapeutic vaccine" was invented by Jonas Nilsson (Umea, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Autologous cancer tumour associated extrachromosomal circular DNA (ecDNA) for use as a therapeutic vaccine against the cancer, and methods for preparing an autologous therapeutic vaccine."

The patent was filed on Feb. 14, 2020, under Application No. 17/426,002.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=...